- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02413684
PackHealth: Asthma Engagement Tool
Assessing the Impact of a Patient-Clinician Engagement Tool on Patient Reported Outcomes and Engagement in Asthma
Visão geral do estudo
Descrição detalhada
Patient engagement is a critical part of improving patient care and outcomes. Current patient engagement strategies only focus on the patient-physician interaction and have been shown to be ineffective.
The need for a comprehensive approach to patient engagement is no different among patients with asthma as it is in any other chronic condition. Patients with asthma must make complicated health decisions daily that impact their social and occupational activities, quality of life, and treatment adherence. Obtaining, communicating, processing, and understanding non- biased health information are crucial in making appropriate and informed treatment decisions.
Pack Health LLC and Duke will develop a patient engagement toolkit known as "Packs" to help empower and engage patients. These disease-specific, evidence-based kits are scientifically designed to improve patient involvement in their own care. Each Pack draws on the science of change management and patient activation and contains three categories of materials
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
North Carolina
-
Durham, North Carolina, Estados Unidos, 27705
- Duke Asthma Allergy and Airway Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Patients with a physician diagnosis of asthma for at least the previous 12 months.
- Asthma that is not well controlled by NAEPP guidelines.
- Ability and willingness to provide informed consent
Exclusion Criteria:
- Significant alcohol consumption of more than three alcoholic drinks per day or active substance abuse.
- Chronic disease (other than asthma) that in the opinion of the investigator would prevent participation in the trial or put the participant at risk by participation e.g. chronic diseases of the lung (other than asthma), heart, liver, kidney, endocrine or nervous system or immunodeficiency that are not well addressed or controlled.
- A diagnosis of cancer with ongoing treatment.
- Any terminal illness or conditions that results in a life expectancy less than one year.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Outro: Asthma Patients
Patient engagement toolkit
|
Pack Health LLC and Duke will develop a patient engagement toolkit known as "Packs" to help empower and engage patients.
These disease-specific, evidence-based kits are scientifically designed to improve patient involvement in their own care
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Rate of Asthma Exacerbations
Prazo: 12 weeks prior to baseline
|
The average number of asthma events requiring treatment with oral corticosteroids, emergency room visits or hospitalizations that occurred 12 weeks before baseline.
|
12 weeks prior to baseline
|
Rate of Asthma Exacerbations
Prazo: baseline to week 13
|
The average number of asthma events requiring treatment with oral corticosteroids, emergency room visits or hospitalizations from baseline to week 13
|
baseline to week 13
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change in Asthma Control
Prazo: baseline, 13 weeks
|
Measured by the Asthma Control Test (ACT), patient self-administered tool for identifying those with poorly controlled asthma.
The ACT assesses the frequency of dyspnea and general asthma symptoms, use of rescue medications, the effect of asthma on daily functioning, and overall self-assessment of asthma control.
5 items with 4-week recall.
The score range is 5-25 with >19 representing good control and <18 representing poor control.
|
baseline, 13 weeks
|
Change in Asthma Symptoms
Prazo: baseline, 13 weeks
|
Measured by asthma symptom utility index (ASUI). The Asthma Symptom utility Index (ASUI) is a brief, interviewer-administered, patient preference-based scale assessing frequency and severity of asthma-related symptoms and treatment side effects. Number of items 11 items with 2 week recall. Scores range from 0 (worst possible symptoms) to 1 (no symptoms) Minimal Clinically Important Difference (MCID) > 0.09 |
baseline, 13 weeks
|
Change in Pulmonary Function Tests
Prazo: baseline, 13 weeks
|
Measured by spirometry.
We measured forced expiratory volume in one second (FEV1) and forced vital capacity both in liters.
FEV1 is a measure of airflow obstruction.
The change in lung function is the change in these measurements compared to baseline.
|
baseline, 13 weeks
|
Number of Emergency Department and Hospitalization Visits
Prazo: Prior Year
|
Number of emergency department and hospitalizations visits will be recorded that occurred within the prior year.
|
Prior Year
|
Number of Emergency Department and Hospitalization Visits
Prazo: 13 weeks
|
Number of emergency department and hospitalization visits will be recorded
|
13 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Njira Lugogo, MD, Duke University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Pro00057939
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Patient engagement toolkit
-
Brigham and Women's HospitalNational Institutes of Health (NIH); National Library of Medicine (NLM)DesconhecidoCâncer | Perda de audição | Cardiomiopatia hipertróficaEstados Unidos, Canadá
-
Oregon Health and Science UniversityTexas A&M University; University of North Carolina, GreensboroAtivo, não recrutandoAtividade físicaEstados Unidos
-
University of MichiganThe Craig H. Neilsen FoundationRecrutamentoLesões da Medula EspinhalEstados Unidos
-
University of SaskatchewanRecrutamentoImagiologia Abdominal Adulto | Imagem abdominal pediátrica | Imagem obstétricaCanadá
-
The Christie NHS Foundation TrustManchester University NHS Foundation Trust; Aptus Clinical Ltd.; Zenzium Ltd.Concluído
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of Health; Bankhead-Coley Cancer Research ProgramConcluídoCâncer colorretal | Carcinoma ColorretalEstados Unidos
-
Florida State UniversityUniversity of Michigan; University of FloridaRecrutamento
-
Children's Hospital Medical Center, CincinnatiRecrutamentoAnemia falciforme | Crianças, SomenteEstados Unidos
-
Imperial College Healthcare NHS TrustConcluído
-
Columbia UniversityNational Institute on Drug Abuse (NIDA); Johns Hopkins University; University... e outros colaboradoresConcluídoHIV | Abuso de substâncias | Paciente internado | AUXILIAEstados Unidos